Activated factor <scp>XI</scp> is associated with increased factor <scp>VIIa</scp> – Antithrombin complexes in stable coronary artery disease: Impact on cardiovascular outcomes-Reference-Cited by-同舟云学术

Activated factor XI is associated with increased factor VIIa – Antithrombin complexes in stable coronary artery disease: Impact on cardiovascular outcomes

Published:2022-08-29 Issue:12 Volume:52 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Investigation

Author:

Paszek Elżbieta¹²^ORCID,Pociask Elżbieta³^ORCID,Ząbczyk Michał²⁴^ORCID,Butenas Saulius⁵,Undas Anetta²⁴^ORCID

Affiliation:

1. Clinical Department of Interventional Cardiology John Paul II Hospital Krakow Poland

2. Department of Thromboembolic Disorders Institute of Cardiology, Jagiellonian University Medical College Krakow Poland

3. Department of Biocybernetics and Biomedical Engineering AGH University of Science and Technology Krakow Poland

4. Krakow Center for Medical Research and Technologies, John Paul II Hospital Krakow Poland

5. Department of Biochemistry University of Vermont Burlington Vermont USA

Funder

Korea National Institute of Health

Uniwersytet Jagielloński Collegium Medicum

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13857

Reference44 articles.

1. Atherosclerosis

2. Fibrin clot properties in coronary artery disease: new determinants and prognostic markers

3. Tissue Factor

4. Tissue factor in atherosclerosis and atherothrombosis

5. The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activated Factor VII–Antithrombin Complex, a Biomarker of Tissue Factor-Related Pathways in Different Clinical Settings: A Narrative Review from Cardiovascular Diseases to Cancer;Diagnostics;2024-08-06

2. Establishment and analysis of artificial neural network diagnosis model for coagulation-related molecular subgroups in coronary artery disease;Frontiers in Genetics;2024-02-29

3. Therapy with ticagrelor/prasugrel is associated with enhanced fibrinolysis and suppressed platelet activation as compared to clopidogrel in chronic coronary syndrome;Kardiologia Polska;2023-11-30

4. Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease;European Journal of Clinical Investigation;2023-04-21